Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 189
Gene Symbol: AGXT
AGXT 		0.100 Biomarker phenotype HPO
Entrez Id: 112817
Gene Symbol: HOGA1
HOGA1 		0.100 Biomarker phenotype HPO
Entrez Id: 9049
Gene Symbol: AIP
AIP 		0.100 Biomarker phenotype HPO
Entrez Id: 353
Gene Symbol: APRT
APRT 		0.100 Biomarker phenotype HPO
Entrez Id: 10320
Gene Symbol: IKZF1
IKZF1 		0.100 Biomarker phenotype HPO
Entrez Id: 7466
Gene Symbol: WFS1
WFS1 		0.100 Biomarker phenotype HPO
Entrez Id: 493856
Gene Symbol: CISD2
CISD2 		0.100 Biomarker phenotype HPO
Entrez Id: 54796
Gene Symbol: BNC2
BNC2 		0.100 Biomarker phenotype HPO
Entrez Id: 3251
Gene Symbol: HPRT1
HPRT1 		0.100 Biomarker phenotype HPO
Entrez Id: 3145
Gene Symbol: HMBS
HMBS 		0.100 CausalMutation phenotype CLINVAR
Entrez Id: 23111
Gene Symbol: SPART
SPART 		0.100 Biomarker phenotype HPO
Entrez Id: 9772
Gene Symbol: TMEM94
TMEM94 		0.100 CausalMutation phenotype CLINVAR
Entrez Id: 3106
Gene Symbol: HLA-B
HLA-B 		0.100 Biomarker phenotype HPO
Entrez Id: 3145
Gene Symbol: HMBS
HMBS 		0.100 Biomarker phenotype HPO
Entrez Id: 83550
Gene Symbol: GPR101
GPR101 		0.100 Biomarker phenotype HPO
Entrez Id: 354
Gene Symbol: KLK3
KLK3 		0.010 AlteredExpression phenotype BEFREE Between October 2013 and December 2016, we performed HIFU hemiablation of the prostate for a total of 35 patients with confirmed PrC stage <cT2a at our urology clinic and retrospectively examined duration of ablation, pre- and postoperative prostate-specific antigen (PSA) levels, prostate volume, erectile function, and dysuria. 31071712 2019
Entrez Id: 152926
Gene Symbol: PPM1K
PPM1K 		0.010 GeneticVariation phenotype BEFREE One treatment-related serious adverse event occurred in each group: dysuria in a patient receiving BDP/FF/G and atrial fibrillation in a patient receiving IND/GLY. 29429593 2018
Entrez Id: 10620
Gene Symbol: ARID3B
ARID3B 		0.010 GeneticVariation phenotype BEFREE One treatment-related serious adverse event occurred in each group: dysuria in a patient receiving BDP/FF/G and atrial fibrillation in a patient receiving IND/GLY. 29429593 2018